Greenstone Biosciences and Intel Partner for AI-Driven Drug Discovery

Greenstone Biosciences and Intel Corporation have announced a strategic collaboration to accelerate drug discovery using artificial intelligence. This partnership will combine Greenstone's human biobank with Intel's advanced Edge AI computing infrastructure. The goal is to expedite new medicine development, enhance drug safety, and advance precision medicine.